Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT07627568

Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition.

Conditions: Acute Myeloid Leukemia

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 20

Sponsor: University of Freiburg

Location: University of Freiburg Mdical Center Freiburg im Breisgau

Summary

The white blood cells of patients with acute myeloid leukemia that have undergone allogeneic stem cell transplantation will be investigated. These are patient where the leukemia has returned after the transplantation.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of acute myeloid leukemia with NPM1 mutations or KMT2A rearrangements * Hematological relapse after allo-HCT * 18 years or older Exclusion Criteria: * no signed informed consent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07627568). StuddyBuddy aggregates publicly available trial information.